Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.
暂无分享,去创建一个
M. Mcgoon | K. Swanson | R. Frantz | M. Krowka | G. Kane | M. Lyle | E. Fenstad | M. McGoon
[1] O. Corcos,et al. Bevacizumab as rescue treatment for severe recurrent gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. , 2013, Journal of clinical gastroenterology.
[2] M. Humbert,et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.
[3] A. Guttmacher,et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia , 2009, Journal of Medical Genetics.
[4] M. Gatzoulis,et al. [Updated clinical classification of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[5] L. Sinak,et al. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. , 2013, Chest.
[6] M. Freire,et al. High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2013, European journal of internal medicine.
[7] R. Trembath,et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia , 2003, Journal of medical genetics.
[8] F. D'Ovidio,et al. Life expectancy in patients with hereditary haemorrhagic telangiectasia. , 2006, QJM : monthly journal of the Association of Physicians.
[9] V. Cottin,et al. Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia (Rendu-Osler Disease) , 2007, Respiration.
[10] A. Stanson,et al. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. , 1999, Mayo Clinic proceedings.
[11] A. Rotondo,et al. Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. , 2004, Radiology.
[12] J. Viale,et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. , 1999, Gastroenterology.
[13] S. Solomon,et al. GUIDELINES AND STANDARDS , 2010 .
[14] Robert I. White,et al. Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[15] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[16] A. Arroliga,et al. Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. , 2007, Chest.
[17] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[18] E. Buscarini,et al. Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia , 2006, Genetics in Medicine.
[19] J. Stockman. Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output , 2013 .
[20] J. Belghiti,et al. Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry , 2006, Annals of surgery.
[21] A. Alexopoulou,et al. Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia , 2013, Expert opinion on biological therapy.
[22] H. Plauchu,et al. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological, and hemodynamic studies of 11 cases. , 1993, Gastroenterology.
[23] D. Badesch,et al. [Definitions and diagnosis of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[24] E. Buscarini,et al. Grade of pulmonary right-to-left shunt on contrast echocardiography and cerebral complications: a striking association. , 2013, Chest.
[25] A. Guttmacher,et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.
[26] A. Torbicki,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[27] J. Simon R. Gibbs,et al. [Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2010, Revue des maladies respiratoires.